Tuesday 4 December 2018

Liposomes Market Research

Liposomes - Market Analytics by Application and by Therapeutic Area - Global Market Insight Report by RI Technologies


Power of Applied Knowledge!
Liposomes market is divided by Application into Therapeutic, Cosmetic and Other; and by Therapeutics into Anti fungal, Anticancer, Ophthalmic and Other.
Liposomes market presents attractive growth opportunities, driven by growing demand for increasingly effective drugs in the field of pharmaceuticals, and niche applications in other emerging areas.”
— Anu Prasad
HYDERABAD, TELANGANA, INDIA, December 4, 2018 /EINPresswire.com/ -- The unique features of Liposome-formulated drugs are that they remain biologically inert, biocompatible and restrict the cause of unwanted toxic or antigenic reactions. They maintain a high level of popularity in the field of drug research. The application of Liposomes have enormously undergone transformations owing to use in the treatment of solid tumors. The tumors are targeted with Liposomes containing bisphosphonate which reduces the tumor associated macrophages. The other important developments such as use of genetic components as therapeutic molecules have further enhanced the scope of Liposomes based therapy. The components of Liposomes present in the lipid-DNA complexes, commonly called lipoplexes, combat with the viral gene transfection systems. The market for liposomes presents attractive growth opportunities, driven by growing demand for increasingly effective drugs in the field of pharmaceuticals, and niche applications in other emerging areas.
RI Technologies' Liposomes Market research report gives an insight into global Liposomes market. The report provides market analytics by application, and by therapeutic area. The market is divided by Application into Therapeutic, Cosmetic and Other; and by Therapeutics into Anti fungal, Anticancer, Ophthalmic and Other. The study also provides information regarding products and technologies in the field of Liposomes. Business profiles of 39 major companies are discussed in the report. The report covers more than 380 companies that are engaged in Liposomes research and supply of products and/or services. Compilation of Worldwide Patents and Research related to Liposomes is also provided. Historic, current, and forecast markets are also illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World with 90 exclusive graphically represented exhibits. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, and other areas of concern is also covered in the report.
Request Sample Pages
Maximize Returns....
Minimize Risks
With our Custom Research Reports exclusively made for you
Unbiased Forecast
Detailed Analysis
Industry Trends
Leading Players
Competitive Information
For Custom Research Enquiries – customresearch@researchimpact.com
For More Information - Contact Us / Email - contactus@researchimpact.com
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –
Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
About RI Technologies
Research Impact Technologies (RIT), www.researchimpact.com, is a premier source of market research in Biotechnology, Healthcare, and Life Science verticals. RIT has completed a decade of excellence in market research. The company has a wide portfolio of market research reports, country reports, company reports, and data exhibits. RIT’s expertise in custom research has helped several worldwide clients and the list of satisfied clients is growing! The company’s reports have evolved over the years and are designed to help companies gain excellence and take their business to the next level. The company has become one of the most successful companies in this space and promises to continue to provide market-defining technologies, products, and services to its clients.
The unique reports are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.
Anu Prasad
RI Technologies
+91 9676994272
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn
Posted by at No comments:

Wednesday 7 November 2018

Global ADME/TOX Market Driven by Efforts of Pharma and Biotech Companies for Reducing Time and Cost of Drug Discovery

ADME/Tox needs to be better understood by strategic decision makers. Risks involved and end use applications should be major areas of research going further.
The toughest challenge in ADME/TOX market is to integrate several successful features and enable pharmaceutical companies to benefit and reap profits in the future.”
— Anu Prasad
HYDERABAD, TELANGANA, INDIA, November 7, 2018 /EINPresswire.com/ -- Global ADME/TOX market is mainly driven by the efforts of pharmaceutical and biotech companies for reducing time and cost of drug discovery. ADME/Tox profiling of a drug candidate plays a key role in reducing clinical trials cost and time of drug launch to the market. ADME/Tox assays eliminate compounds with lack of bioavailability, lower efficacy and toxicity in early stages, in order to save time and costs in expensive later stages of drug discovery.
This ADME/Tox Market research report gives an insight into products and services used in the ADME/Tox industry. Predictive technologies analyzed include In vivo, In vitro, and In silico. Related technologies such as High Throughput Screening (HTS), Laboratory Information Management System (LIMS), and cell based assays are also analyzed. Market projections and estimates are illustrated by region and by technology. The report serves as a guide to ADME/Tox industry, covering more than 350 companies that are engaged in ADME/Tox Market size/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the ADME/Tox industry are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to ADME/Tox Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa with 93 exclusive graphically represented exhibits. Key trends analyzed include ADME/TOX market growth, ADME Tox market potential, market shares, market size, and other market critical factors. This ADME/Tox market research provides historical, current, and market forecasts.
Need of the Study
The current study is quite useful in choosing the right technology at the right time to conduct ADME/Tox screening of a drug candidate, to save time and money in the process of obtaining regulatory approval. ADME/Tox is a science that needs to be better understood by strategic decision makers. The risks involved and the end use applications should be major areas of research going further. ADME/Tox is considered a major hurdle in drug discovery today. Companies that produce state-of- art tools and focus on complete solutions will be clear winners. Automation is the way to go with emphasis on lower costs. Clearly, animal models cannot be totally overruled owing to the traditional concerns, and also the comfort level involved since they provide the closest biological environment to human systems.
New technologies in ADME/Tox have evolved from diverse scientific disciplines. The toughest challenge is to integrate several successful features and enable pharmaceutical companies to benefit and reap profits in the future. Though some of the concepts in this industry are still in infant stages, the data generated from other relevant sources can be used to close the gaps. Pharmaceutical companies realize the potential of ADME/Tox technologies and are trying more than before to incorporate innovative procedures to reduce drug attrition rates and lessen the burden of costs and save precious time.
Strategic partnerships between pharmaceutical and biotechnology companies are the order of the day, and the trend is increasing globally. Another significant trend is the alliance between Pharma and Biotech companies and information technology companies such as Microsoft, IBM, Oracle, Sun, and Infosys, etc. The computer platforms generated by such companies help managing and analyzing the huge amounts of data produced from ADME/Tox technologies such as High Throughput Screening (HTS) and other computational techniques. Effective R&D strategy involves efficient data management and implementation plans. The new technologies promise improved efficacy, decreased toxicity in patients, and reduced time frames and expenditures.
Maximize Returns....
Minimize Risks
With our Custom Research Reports exclusively made for you
Unbiased Forecast
Detailed Analysis
Industry Trends
Leading Players
Competitive Information
For Custom Research Enquiries – customresearch@researchimpact.com
For More Information - Contact Us / Email - contactus@researchimpact.com
About RI Technologies
Research Impact Technologies (RIT), www.researchimpact.com, is a premier source of market research in Biotechnology, Healthcare, and Life Science verticals. RIT has completed a decade of excellence in market research. The company has a wide portfolio of market research reports, country reports, company reports, and data exhibits. RIT’s expertise in custom research has helped several worldwide clients and the list of satisfied clients is growing! The company’s reports have evolved over the years and are designed to help companies gain excellence and take their business to the next level. The company has become one of the most successful companies in this space and promises to continue to provide market-defining technologies, products, and services to its clients.
The unique reports are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

Anu Prasad
RI Technologies
+91 9676994272
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn
Posted by at No comments:

Monday 29 January 2018

Genomics and Proteomics Research Fuel Global High Throughput Screening Market

The success of the Human Genome Project generated huge number of drug targets requiring HTS. The global HTS market is expected to be USD 43 billion by 2022.
Lead discovery by HTS has gained momentum and has evolved into a mature scientific discipline in modern drug discovery. Lesser time and lower costs fuel the HTS processes, aided by miniaturization.”
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, January 29, 2018 /EINPresswire.com/ -- RI Technologies' exclusive report on High Throughput Screening (HTS) emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas. The major technologies analyzed include Ultra High Throughput Screening, High Content Screening, Bioinformatics and Microfluidics/Lab-On-a-Chip; and the major product segments encompass HTS Services and HTS Tools. The global markets for Novel High Throughput Screening Products and Cell Based Assays are also discussed in the report. Markets covered for Microfluidics and Bioinformatics pertain to the applications of HTS. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 500 companies that are engaged in HTS services and/or production of HTS tools/instruments. Major Contract Research Organizations serving HTS industry are also covered in the corporate directory section of this report. Estimations and predictions are graphically represented by region, by technology and by product segment. Compilation of Worldwide Patents and Research related to High Throughput Screening is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific and Rest of World. The market is analyzed in US Dollars and includes 109 exclusive exhibits. High throughput screening market size, market review, market shares, and other key market results and trends are analyzed.
RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data.
You can now avail 25% discount on the report. Free customization (100%) on report for Early Buyers.
High Throughput Screening (HTS) market is growing at a robust rate over the past few years, driven by the technological advancements in fields such as genomic and proteomic research. Genomics and proteomics findings and the success of the Human Genome Project generated enormous number of drug targets that require HTS. Along with these factors, other important sources of targets for new drugs comprise usage of sophisticated tools such as protein arrays and DNA microarrays; and pressure by the investors on pharma companies to bring more drugs to the market. Pharmaceutical companies are employing innovative screening techniques to speed up the screening process and cut short the new drug’s time to the market. The phenomenon is creating an amazing market opportunity for HTS.
Strategic partnerships between pharmaceutical and biotechnology companies are the order of the day, and the trend is increasing globally. Another significant trend is the growing alliances between Pharma and Biotech companies and information technology companies such as Microsoft, IBM, Oracle, Sun, and Infosys, etc. The computer platforms generated by such companies help in managing and analyzing the huge amounts of data produced through High Throughput Screening (HTS) and other computational techniques. Effective R&D strategy involves efficient data management and implementation plans. The new technologies promise improved efficacy, decreased toxicity in patients, and reduced time frames and expenditures.
Why Buy this Report?
High Throughput Screening report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, companies and drug approval authorities in –
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets
USP
Maximize Returns....
Minimize Risks
• Unbiased Forecast
• Detailed Analysis
• Industry Trends
• Leading Players
• Competitive Information
For Custom Research Enquiries – customresearch@researchimpact.com
For More Information - Contact Us / Email - contactus@researchimpact.com
About RI Technologies
Research Impact Technologies (RIT), www.researchimpact.com, is a premier source of market research in Biotechnology, Healthcare, and Life Science verticals. RIT has completed a decade of excellence in market research. The company has a wide portfolio of market research reports, country reports, company reports, and data exhibits. RIT’s expertise in custom research has helped several worldwide clients and the list of satisfied clients is growing! The company’s reports have evolved over the years and are designed to help companies gain excellence and take their business to the next level. The company has become one of the most successful companies in this space and promises to continue to provide market-defining technologies, products, and services to its clients.
The unique reports are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

Anasuya Vemuri
RI Technologies
91 9676994272
Posted by at No comments:
Subscribe to: Posts (Atom)